ID27299A - Senyawa-senyawa arsen sulfida dan turunan-turunannya untuk mengobati maglinansis - Google Patents

Senyawa-senyawa arsen sulfida dan turunan-turunannya untuk mengobati maglinansis

Info

Publication number
ID27299A
ID27299A IDW20002443A ID20002443A ID27299A ID 27299 A ID27299 A ID 27299A ID W20002443 A IDW20002443 A ID W20002443A ID 20002443 A ID20002443 A ID 20002443A ID 27299 A ID27299 A ID 27299A
Authority
ID
Indonesia
Prior art keywords
compounds
present
sulfida
maglinansis
arsen
Prior art date
Application number
IDW20002443A
Other languages
English (en)
Inventor
Lu Daopei
Original Assignee
Lu Da Opei Staff Living Quarte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lu Da Opei Staff Living Quarte filed Critical Lu Da Opei Staff Living Quarte
Publication of ID27299A publication Critical patent/ID27299A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treating Waste Gases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
IDW20002443A 1998-04-24 1998-07-06 Senyawa-senyawa arsen sulfida dan turunan-turunannya untuk mengobati maglinansis ID27299A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98101635A CN1233476A (zh) 1998-04-24 1998-04-24 治疗急性白血病的药物及其制备方法

Publications (1)

Publication Number Publication Date
ID27299A true ID27299A (id) 2001-03-22

Family

ID=5216829

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002443A ID27299A (id) 1998-04-24 1998-07-06 Senyawa-senyawa arsen sulfida dan turunan-turunannya untuk mengobati maglinansis

Country Status (18)

Country Link
US (2) US6733792B1 (id)
EP (2) EP1077709B1 (id)
JP (1) JP2002512967A (id)
KR (1) KR100610388B1 (id)
CN (2) CN1233476A (id)
AT (1) ATE292974T1 (id)
AU (1) AU748795B2 (id)
BR (1) BR9815825A (id)
CA (1) CA2328165A1 (id)
DE (1) DE69829782T2 (id)
ES (1) ES2242286T3 (id)
ID (1) ID27299A (id)
IL (1) IL139208A (id)
NO (1) NO20005315D0 (id)
NZ (2) NZ526746A (id)
PL (1) PL344410A1 (id)
TR (1) TR200003117T2 (id)
WO (1) WO1999055344A1 (id)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519366A (ja) 1997-10-15 2001-10-23 ポーラクス バイオファーマシュティカルズ，インコーポレーテッド ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
IL136051A0 (en) 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
FR2781674B1 (fr) * 1998-07-31 2002-06-28 Inst Nat Sante Rech Med Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
US6911471B2 (en) * 2002-01-07 2005-06-28 The Texas A&M University System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US20030235571A1 (en) * 2002-06-19 2003-12-25 Gabriel Gojon-Romanillos Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
CA2504935C (en) 2002-11-07 2012-04-10 Newsouth Innovations Pty Limited Induction of the mitochondrial permeability transition
EP2633866A3 (en) * 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
ES2532666T3 (es) 2005-07-29 2015-03-30 Solasia Pharma K.K. Compuestos y métodos para el tratamiento del cáncer
WO2007035755A2 (en) * 2005-09-19 2007-03-29 Duke University Methods of treating hematological malignancies
US20080233207A1 (en) * 2006-01-04 2008-09-25 Sheptovitsky Yelena G Injectable and Infusable Mercury Compositions and Methods for Treating Cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
JP5301449B2 (ja) 2006-11-01 2013-09-25 ニューサウス イノベイションズ ピーティーワイ リミテッド 有機アルセノキシド化合物およびその使用
KR20100100835A (ko) * 2007-11-02 2010-09-15 지오팜 온콜로지 인코포레이티드 유기 비소제와의 병용 요법
SG186599A1 (en) * 2007-12-12 2013-01-30 Ziopharm Oncology Inc Compounds and methods for the treatment of cancer
RU2534606C2 (ru) 2008-08-20 2014-11-27 Зайофарм Онколоджи, Инк. Мышьякорганические соединения и способы лечения рака
PT2475362T (pt) * 2009-09-10 2019-05-27 Kominox Inc Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
FR3004949B1 (fr) * 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
CN104434971A (zh) * 2014-02-28 2015-03-25 贺鹏程 一种用于治疗急性早幼粒细胞白血病的复方制剂、及其药物组合物、应用和制备方法
CN108498542A (zh) * 2017-02-24 2018-09-07 四川兴科蓉药业有限责任公司 β-As4S4在制备用于治疗血液系统恶性肿瘤的药物中的用途
WO2019134070A1 (en) * 2018-01-02 2019-07-11 Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine Panda as novel therapeutic
WO2019134650A1 (en) * 2018-01-02 2019-07-11 Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine Mp53 rescue compounds and methods of treating a p53 disorder
CN108338990A (zh) * 2018-04-11 2018-07-31 中国医学科学院基础医学研究所 水溶性雄黄固体分散体在制备骨髓造血干/祖细胞红系分化诱导剂中的应用
CN109528646A (zh) * 2018-11-21 2019-03-29 南京泽恒医药技术开发有限公司 一种巯嘌呤混悬液及其制备方法
CN110101713A (zh) * 2019-05-16 2019-08-09 上海交通大学医学院附属第九人民医院 一种三氧化二砷组合物的应用
ES2952205T3 (es) * 2019-05-21 2023-10-30 Medsenic Uso de iones de cobre para potenciar los efectos terapéuticos del arsénico
CN112870225B (zh) * 2021-02-05 2023-01-06 北京大学人民医院 一种用于高危急性早幼粒细胞白血病诱导期的联合治疗药物
CN116338184B (zh) * 2023-04-24 2025-09-16 峰春源医疗器械(深圳)有限公司 一种高安全性新冠病毒抗原检测试剂盒
NL2039297B1 (en) * 2024-12-11 2025-07-18 Inst Chinese Materia Medica China Academy Of Cms Application of Realgar in the Preparation of Drugs for The Prevention and/or Treatment of Acute Promyelocytic Leukemia

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132275A (en) 1872-10-15 Improvement in medical compounds
US232807A (en) 1880-10-05 Herbert e
US3700498A (en) 1970-12-10 1972-10-24 Ibm Process for making electrophotographic plates
JPS5129726A (id) 1974-09-06 1976-03-13 Mitsubishi Heavy Ind Ltd
JPS5188620A (en) 1975-01-31 1976-08-03 Jintainokenkonoiji kotonigannitaishitekonoojusuru noshukuionekinoseizoho
DE3003635C2 (de) 1980-02-01 1985-07-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Verfahren und Vorrichtung zur Entarsenierung arsenhaltiger Materialien
FR2539993A1 (fr) 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
GB2226494B (en) * 1988-07-20 1991-10-09 Poon Theodore Man Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
US5759837A (en) 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
CN1061908A (zh) * 1991-12-21 1992-06-17 江西省妇产医院 一种治癌药物的制造方法
CN1060935C (zh) 1992-05-31 2001-01-24 丛繁滋 用于癌病灶直接给药的砷制剂的制备方法
CN1044777C (zh) 1992-07-06 1999-08-25 杨世泽 癌痛止痛膏的配制方法
KR100329245B1 (ko) 1992-07-24 2002-03-18 더 존스 홉킨스 유니버시티 종양 세포의 발병도를 측정하는 것을 돕는 생체외 분석방법
DE4317331A1 (de) 1993-05-25 1994-12-01 Reischle Karl Georg Behandlung von Schädigungen des Immunsystems
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
EP0804928B1 (en) 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
CN1119113A (zh) 1994-09-22 1996-03-27 衣永德 复方癌复康胶囊及制备方法
CN1122700A (zh) 1994-11-08 1996-05-22 付知中 一种治疗乳腺疾病、肿瘤疮毒的散剂及其制备方法
LV11667B (en) 1995-08-14 1997-06-20 Tamara Vorobieva Remedy for renewal of disordered function of immunomodulation and cell tissue reproduction adjustors
CN1044559C (zh) 1995-08-23 1999-08-11 哈尔滨医科大学附属第一医院 抗白血病、肝癌、淋巴瘤注射液
CN1058620C (zh) 1995-11-12 2000-11-22 卢颖 一种治疗癌症的外用中成药及配备生产工艺
CN1052648C (zh) 1995-12-03 2000-05-24 唐书生 癌瘤消肿止痛膏
JP2001519366A (ja) * 1997-10-15 2001-10-23 ポーラクス バイオファーマシュティカルズ，インコーポレーテッド ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
IL136051A0 (en) 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

Also Published As

Publication number Publication date
NO20005315L (no) 2000-10-20
HK1034466A1 (en) 2001-10-26
EP1077709B1 (en) 2005-04-13
NO20005315D0 (no) 2000-10-20
DE69829782D1 (de) 2005-05-19
EP1077709A4 (en) 2002-06-19
IL139208A0 (en) 2001-11-25
AU8100998A (en) 1999-11-16
DE69829782T2 (de) 2006-03-09
TR200003117T2 (tr) 2001-03-21
CN1233476A (zh) 1999-11-03
NZ526746A (en) 2005-01-28
CN1175823C (zh) 2004-11-17
KR20010071160A (ko) 2001-07-28
US7138147B2 (en) 2006-11-21
CA2328165A1 (en) 1999-11-04
EP1077709A1 (en) 2001-02-28
PL344410A1 (en) 2001-11-05
US6733792B1 (en) 2004-05-11
ATE292974T1 (de) 2005-04-15
KR100610388B1 (ko) 2006-08-09
CN1299284A (zh) 2001-06-13
BR9815825A (pt) 2000-12-12
IL139208A (en) 2005-08-31
JP2002512967A (ja) 2002-05-08
US20040028750A1 (en) 2004-02-12
WO1999055344A1 (en) 1999-11-04
AU748795B2 (en) 2002-06-13
ES2242286T3 (es) 2005-11-01
EP1552841A1 (en) 2005-07-13
NZ508240A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
ID27299A (id) Senyawa-senyawa arsen sulfida dan turunan-turunannya untuk mengobati maglinansis
BR0214230A (pt) Compostos e processos de fabricação de compostos
DE69435118D1 (de) Gereinigte Zusammensetzungen von Newcastle-Krankheitvirus
DE69725825D1 (de) 5-HT1F-Agonisten
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
DE69105635D1 (de) Dibenzoylalkylcyanohydrazine.
ES2178459T3 (es) Fosfohalohidrinas, procedimiento de fabricacion y aplicaciones.
BR0316421A (pt) Composição farmacêutica compreendendo micropartìculas de octreotìdeo
DE60039354D1 (de) Verfahren zur Stabilisierung von chimären Immunoglobulinen oder Immunoglobulinfragmenten und stabilisiertes Anti-EGP-2-scFv-Fragment
BR9100372A (pt) Processo de sintese de compostos binarios de enxofre,composto sulfurado de terras raras,mistura de compostos sulfurados,sesquissulfetos de terras raras e sulfeto de metal de transicao
FR2831534B1 (fr) Composition photoactivable et utilisations
BR9900114A (pt) Composições de ciclodextrina.
PT796618E (pt) Tratamento e profilaxia da pancreatite
DE69013787D1 (de) Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren.
NO932192D0 (no) Fremgangsmaate ved fremstilling av metyltritio - anti - tumorforbindelser
DE69730796D1 (de) Naphthylverbindungen, Zusammensetzungen und Verfahren
ID25478A (id) Agonis 5-ht1f
ATE425140T1 (de) Mercaptane und disulfide
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
DE60126994D1 (de) Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman
MX9303643A (es) Procedimiento para la fabricacion de fibras de poli(sulfuro de arileno) y multifilamentos de poli(sulfuro de arinelo) obtenibles segun dicho procedimiento.
BR9804638A (pt) Processo para reduzir o comprimento de cadeia de sulfano de bis-(sililorganil)-polissulfanos.
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler